Improvements in Cardiopulmonary Exercise Test Results in Atrial Fibrillation Patients After Radiofrequency Ablation in Kazakhstan
Diagnostics · 22.10.2024 · 14 (21) · 2355
DOI: 10.3390/diagnostics14212355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 22.10.2024. Verfasst von Akmaral Beisenbayeva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Corporate Fund "University Medical Center", Heart Center, Astana 010000, Kazakhstan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This prospective study evaluates the impact of radiofrequency ablation (RFA) on cardiorespiratory indicators in patients with long-standing persistent atrial fibrillation admitted to the Heart Center UMC between January 2022 and April 2024 in Astana, Kazakhstan. The study aims to assess the functional cardiac benefits of RFA. Out of 717 registered atrial fibrillation patients, 104 were examined before and 3 months after ablation, focusing on cardiorespiratory parameters. A before-and-after analysis using linear mixed models was applied to evaluate changes in cardiorespiratory parameters post-RFA. Significant improvements were noted across various measures. VO2 max increased from 11.5 ± 4.4 mL/kg/min to 18.0 ± 4.5 mL/kg/min (p < 0.001). Oxygen uptake improved from 7.2 ± 2.6 mL/beat to 11.0 ± 3.4 mL/beat (p < 0.001). The 6-min walking test distance rose from 306 ± 82 m to 400 ± 48 m (p < 0.001). METs increased from 4.4 ± 1.6 to 8.0 ± 1.3 (p < 0.001). Heart rate at peak exercise decreased from 175.5 ± 18.6 to 147.2 ± 12.3 beats per minute (p < 0.001). NT-proBNP levels decreased from 1357 ± 1182 to 415 ± 339 pg/mL (p < 0.001). Patients with persistent atrial fibrillation undergoing RFA showed functional improvements in CPET indicators such as VO2 max, METs, O2 pulse, heart rate, and the 6-min walking test. Improvements were also seen in Nt-proBNP analysis. These results emphasize the need for longitudinal follow-up to optimize outcomes and minimize medical risks.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Corporate Fund "University Medical Center", Heart Center, Astana 010000, Kazakhstan.
- Department of Cardiology, Non-Profit Joint Stock Company "Medical University Astana", Astana 010000, Kazakhstan.
- Republican Specialized Scientific Practical-Medical Center of Cardiology, Astana 010000, Kazakhstan.
- Department of Medicine, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
ORCID-Profile: Akmaral Beisenbayeva, Abay Bakytzhanuly, Uldana Aleushinova, Feruza Bekmetova, Assel Chinybayeva, Altynay Beyembetova
Zitieren
APA
Beisenbayeva, A., Bekbossynova, M., Bakytzhanuly, A., Aleushinova, U., Bekmetova, F., Chinybayeva, A., Abdrakhmanov, A., & Beyembetova, A. (2024). Improvements in Cardiopulmonary Exercise Test Results in Atrial Fibrillation Patients After Radiofrequency Ablation in Kazakhstan. Diagnostics, 14(21), 2355. https://doi.org/10.3390/diagnostics14212355
Vancouver
Beisenbayeva A, Bekbossynova M, Bakytzhanuly A, Aleushinova U, Bekmetova F, Chinybayeva A, et al. Improvements in Cardiopulmonary Exercise Test Results in Atrial Fibrillation Patients After Radiofrequency Ablation in Kazakhstan. Diagnostics. 2024;14(21):2355. doi:10.3390/diagnostics14212355
BibTeX
@article{Beisenbayeva2024,
author = {Beisenbayeva, Akmaral and Bekbossynova, Makhabbat and Bakytzhanuly, Abay and Aleushinova, Uldana and Bekmetova, Feruza and Chinybayeva, Assel and Abdrakhmanov, Ayan and Beyembetova, Altynay},
title = {Improvements in Cardiopulmonary Exercise Test Results in Atrial Fibrillation Patients After Radiofrequency Ablation in Kazakhstan},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {21},
pages = {2355},
doi = {10.3390/diagnostics14212355}
}
EUVIMED